Primary Extremity Soft Tissue Sarcomas: Does Local Control Impact Survival?
Sylvie Bonvalot(Dana-Farber Cancer Institute), C. Le Péchoux(Institut Gustave Roussy), Axel Le Cesne(Institut Gustave Roussy), Philippe Terrier(Institut Gustave Roussy), S. Bellefqih(Université Paris-Saclay), Antonin Lévy(Inserm), Dimitri Tzanis(Université Paris Cité)
Cited by 93
Related Papers
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
|Annals of Oncology|2021|978